Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Natera, Inc. | Director | Common Stock | 15.8K | $2.37M | $149.98 | Nov 15, 2024 | Direct |
Travere Therapeutics, Inc. | Director | Common Stock | 31K | $209K | $6.74 | May 8, 2024 | Direct |
Atara Biotherapeutics, Inc. | Director | Common Stock | 43.5K | $16.9K | $0.39 | Jun 23, 2022 | Direct |
Natera, Inc. | Director | Stock Option (right to buy) | 0 | $0 | $25.03 | Nov 15, 2024 | Direct |
Atara Biotherapeutics, Inc. | Director | Non-Qualified Stock Option (Right to Buy) | 31.5K | Jun 23, 2022 | Direct | ||
Travere Therapeutics, Inc. | Director | Stock option (right to buy) | 19.5K | May 8, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NTRA | Natera, Inc. | Nov 15, 2024 | 10 | -$4.57M | 4 | Nov 15, 2024 | Director |
NTRA | Natera, Inc. | Oct 25, 2024 | 1 | $0 | 4 | Oct 29, 2024 | Director |
NTRA | Natera, Inc. | Jul 26, 2024 | 1 | $0 | 4 | Jul 30, 2024 | Director |
NTRA | Natera, Inc. | Jun 28, 2024 | 1 | $0 | 4 | Jul 2, 2024 | Director |
TVTX | Travere Therapeutics, Inc. | May 8, 2024 | 2 | $0 | 4 | May 10, 2024 | Director |
NTRA | Natera, Inc. | Apr 26, 2024 | 1 | $0 | 4 | Apr 30, 2024 | Director |
NTRA | Natera, Inc. | Jan 26, 2024 | 1 | $13.7K | 4 | Jan 30, 2024 | Director |
NTRA | Natera, Inc. | Oct 27, 2023 | 1 | $13.7K | 4 | Oct 31, 2023 | Director |
NTRA | Natera, Inc. | Jul 28, 2023 | 1 | $12.8K | 4 | Aug 1, 2023 | Director |
NTRA | Natera, Inc. | Jun 30, 2023 | 2 | $0 | 4 | Jul 5, 2023 | Director |
NTRA | Natera, Inc. | May 25, 2023 | 2 | $0 | 4 | May 26, 2023 | Director |
TVTX | Travere Therapeutics, Inc. | May 17, 2023 | 2 | $0 | 4 | May 19, 2023 | Director |
NTRA | Natera, Inc. | Apr 14, 2023 | 1 | $12.5K | 4 | Apr 18, 2023 | Director |
NTRA | Natera, Inc. | Jan 13, 2023 | 1 | $12.5K | 4 | Jan 18, 2023 | Director |
NTRA | Natera, Inc. | Oct 14, 2022 | 1 | $12.5K | 4 | Oct 18, 2022 | Director |
NTRA | Natera, Inc. | Jul 8, 2022 | 1 | $0 | 4/A | Sep 2, 2022 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 23, 2022 | 2 | $0 | 4 | Jun 27, 2022 | Director |
NTRA | Natera, Inc. | May 27, 2022 | 2 | $0 | 4 | Jun 1, 2022 | Director |
NTRA | Natera, Inc. | May 25, 2022 | 2 | $0 | 4 | May 27, 2022 | Director |
TVTX | Travere Therapeutics, Inc. | May 11, 2022 | 2 | $0 | 4 | May 12, 2022 | Director |
ATRA | Atara Biotherapeutics, Inc. | Jun 8, 2021 | 2 | $0 | 4 | Jun 9, 2021 | Director |
NTRA | Natera, Inc. | May 28, 2021 | 4 | $0 | 4 | Jun 2, 2021 | Director |
TVTX | Travere Therapeutics, Inc. | May 14, 2021 | 2 | $0 | 4 | May 18, 2021 | Director |